Coldstream Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$522K	Buy	1,602 +523	+48%	+$171K	0.01%	636
2025 Q1	$291K	Sell	1,079 -34	-3%	-$9.18K	0.01%	824
2024 Q4	$262K	Sell	1,113 -98	-8%	-$23.1K	0.01%	892
2024 Q3	$329K	Buy	1,211 +368	+44%	+$100K	0.01%	791
2024 Q2	$205K	Buy	+843	New	+$205K	0.01%	936